Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Alimera Sciences Inc (ALIM)

Alimera Sciences Inc (ALIM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 55,002
  • Shares Outstanding, K 5,753
  • Annual Sales, $ 50,820 K
  • Annual Income, $ -5,340 K
  • 60-Month Beta 1.83
  • Price/Sales 1.07
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ALIM with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.50
  • Number of Estimates 1
  • High Estimate -0.50
  • Low Estimate -0.50
  • Prior Year -0.24
  • Growth Rate Est. (year over year) -108.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.60 +25.79%
on 03/10/21
12.25 -21.96%
on 03/19/21
+2.04 (+27.13%)
since 03/09/21
3-Month
5.40 +77.04%
on 01/12/21
12.25 -21.96%
on 03/19/21
+3.76 (+64.83%)
since 01/08/21
52-Week
3.82 +150.20%
on 11/03/20
12.25 -21.96%
on 03/19/21
+5.55 (+138.40%)
since 04/09/20

Most Recent Stories

More News
Alimera Sciences to Present at the Zooming with LD Micro Virtual Conference on April 15, 2021

Alimera Sciences, Inc. (Nasdaq: ALIM) ("Alimera"), a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmology treatments for the management of retinal...

ALIM : 9.56 (+1.49%)
Global Uveitis Drugs Market- AbbVie Inc., Alimera Sciences Inc., Amgen Inc., among others to contribute to the market growth|Industry Analysis, Market Trends, Market Growth, Opportunities and Forecast 2025

, /PRNewswire/ --

ABBV : 107.54 (+1.36%)
ALIM : 9.56 (+1.49%)
AMGN : 248.95 (+0.84%)
Ocular Drug Delivery Technology Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027

The Global is estimated to value over USD 19 billion by 2027 end with a CAGR of over 6.8% during the forecast period 2020 to 2027.

ALIM : 9.56 (+1.49%)
AGN : 193.02 (+0.02%)
SNPHF : 14.0000 (+2.19%)
VRX.TO : 30.80 (-3.33%)
Alimera Sciences to Participate in Benzinga Biotech Small Cap Conference

Alimera Sciences, Inc. (Nasdaq: ALIM) ("Alimera"), a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmology treatments for the management of retinal...

ALIM : 9.56 (+1.49%)
Alimera Sciences Continues to Execute on Its Expansion Strategy in Denmark and Luxembourg, and Achieves Extended Reimbursement in Ireland

Alimera Sciences, Inc. (Nasdaq: ALIM) ("Alimera"), a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmology treatments for the management of retinal...

ALIM : 9.56 (+1.49%)
Ocular Inflammation Treatment Market Size, Status, Demand, Growth and Overview Outlook 2020 - 2025

The is expected to exceed more than US$ 500 Billion by 2024 at a CAGR of 6% in the given forecast period.

AKRX : 0.0900 (-51.01%)
ALIM : 9.56 (+1.49%)
AGN : 193.02 (+0.02%)
NVS : 87.55 (+0.64%)
PFE : 36.60 (+1.78%)
VRX.TO : 30.80 (-3.33%)
Alimera Sciences to Present at Maxim Group's Inaugural Emerging Growth Virtual Conference

Alimera Sciences, Inc. (Nasdaq: ALIM) ("Alimera"), a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmology treatments for the management of retinal...

ALIM : 9.56 (+1.49%)
Alimera Sciences to Present at the H.C. Wainwright Global Life Sciences Conference

Alimera Sciences, Inc. (Nasdaq: ALIM) ("Alimera"), a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmology treatments for the management of retinal...

ALIM : 9.56 (+1.49%)
Intravitreal (IVT) Injectables Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027

The Global is poised to register a CAGR of over 4.7% during the forecast period 2020 to 2027.

ALIM : 9.56 (+1.49%)
AGN : 193.02 (+0.02%)
NVS : 87.55 (+0.64%)
REGN : 475.17 (-0.25%)
VRX.TO : 30.80 (-3.33%)
Alimera Sciences: 4Q Earnings Snapshot

ALPHARETTA, Ga. (AP) _ Alimera Sciences Inc. (ALIM) on Wednesday reported a fourth-quarter loss of $977,000, after reporting a profit in the same period a year earlier.

ALIM : 9.56 (+1.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Alimera Sciences, Inc., based in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company is presently focused on diseases affecting the back of the eye, or retina because it believes...

See More

Key Turning Points

3rd Resistance Point 10.36
2nd Resistance Point 10.03
1st Resistance Point 9.79
Last Price 9.56
1st Support Level 9.23
2nd Support Level 8.90
3rd Support Level 8.67

See More

52-Week High 12.25
Last Price 9.56
Fibonacci 61.8% 9.03
Fibonacci 50% 8.04
Fibonacci 38.2% 7.04
52-Week Low 3.82

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar